• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性和转移性人类前列腺癌中p53突变的频率及特征

Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer.

作者信息

Dinjens W N, van der Weiden M M, Schroeder F H, Bosman F T, Trapman J

机构信息

Department of Pathology, Erasmus University, Rotterdam, The Netherlands.

出版信息

Int J Cancer. 1994 Mar 1;56(5):630-3. doi: 10.1002/ijc.2910560504.

DOI:10.1002/ijc.2910560504
PMID:8314337
Abstract

We have studied the frequency of mutations in the p53 gene in human prostate cancer. The investigated material consisted of 20 primary-tumor tissue specimens, obtained by transurethral resection and tissue specimens of 15 lymph-node metastases, obtained at total prostatectomy. The applied methods encompassed immunohistochemistry on frozen sections, using the monoclonal antibody PAb 1801, and single-strand conformation polymorphism (SSCP) analysis, after amplification of single exon sequences by PCR, on exons 5 to 8 of the p53 gene. The mutations, leading to aberrantly migrating bands in the PCR-SSCP analysis, were identified by direct sequencing of the PCR product. Immunohistochemical and PCR-SSCP analysis were completely confirmative. In the primary tumors, mutations were found in 10% of the specimens (codons 232 and 273), and in lymph-node metastases in 15% of the specimens (codons 248 and 273). In one case (codon 273), the same mutation was found both in the primary tumor and in the lymph-node metastasis. Our results show that p53 mutations are infrequent in both primary and metastatic prostate tumors. In addition, they indicate that there is no strict correlation between p53 mutation and tumor metastasis.

摘要

我们研究了人类前列腺癌中p53基因的突变频率。所研究的材料包括20份经尿道切除获得的原发性肿瘤组织标本,以及15份在前列腺全切术中获得的淋巴结转移灶组织标本。应用的方法包括在冰冻切片上进行免疫组织化学分析,使用单克隆抗体PAb 1801,以及在通过PCR扩增p53基因第5至8外显子的单外显子序列后,进行单链构象多态性(SSCP)分析。通过对PCR产物进行直接测序来鉴定在PCR-SSCP分析中导致异常迁移条带的突变。免疫组织化学分析和PCR-SSCP分析结果完全一致。在原发性肿瘤中,10%的标本(密码子232和273)发现有突变,在淋巴结转移灶中,15%的标本(密码子248和273)发现有突变。在1例(密码子273)中,在原发性肿瘤和淋巴结转移灶中均发现相同的突变。我们的结果表明,p53突变在原发性和转移性前列腺肿瘤中均不常见。此外,结果表明p53突变与肿瘤转移之间没有严格的相关性。

相似文献

1
Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer.原发性和转移性人类前列腺癌中p53突变的频率及特征
Int J Cancer. 1994 Mar 1;56(5):630-3. doi: 10.1002/ijc.2910560504.
2
p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.p53蛋白积累与基因突变在人类前列腺癌进展中的作用
J Natl Cancer Inst. 1993 Oct 20;85(20):1657-69. doi: 10.1093/jnci/85.20.1657.
3
P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer.P53肿瘤抑制基因突变主要定位于人类原发性和转移性前列腺癌的第7外显子。
Br J Cancer. 1996 Jul;74(2):264-8. doi: 10.1038/bjc.1996.349.
4
Frequency and characterization of p53 mutations in clinically localized prostate cancer.临床局限性前列腺癌中p53突变的频率及特征
Urology. 1995 Mar;45(3):470-5. doi: 10.1016/s0090-4295(99)80018-1.
5
p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.原发性前列腺癌中的p53异常:与基因组DNA相比,互补DNA的单链构象多态性分析。前列腺癌协作网络。
J Natl Cancer Inst. 1997 Jan 1;89(1):66-71. doi: 10.1093/jnci/89.1.66.
6
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.携带p53突变的原发性人类前列腺癌细胞在转移灶中发生克隆性扩增。
Clin Cancer Res. 1997 Aug;3(8):1389-97.
7
A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.人类肾癌中一个位于密码子132(AAG→AGG)的新型p53突变热点。
Biochem Mol Biol Int. 1998 Feb;44(2):407-15. doi: 10.1080/15216549800201422.
8
p53 in prostate cancer: frequent expressed transition mutations.前列腺癌中的p53:频繁表达的转换突变
J Natl Cancer Inst. 1994 Jun 15;86(12):926-33. doi: 10.1093/jnci/86.12.926.
9
Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors.转移性前列腺癌及配对原发性肿瘤中p53突变极为常见。
Cancer. 1998 Dec 15;83(12):2534-9.
10
Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.原发性和转移性胰腺导管病变的分子病理学:散发性和家族性病变中p53、mdm-2和p21/WAF-1基因的突变及表达分析
Cancer. 1997 Feb 15;79(4):700-16.

引用本文的文献

1
A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.一种具有 Pten 和 p53 缺失的异质性、c-MYC 起始的前列腺癌的小鼠模型。
Oncogene. 2012 Jan 19;31(3):322-32. doi: 10.1038/onc.2011.236. Epub 2011 Jun 20.
2
Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.前列腺癌转移的分子标志物。开发预测前列腺癌侵袭性的诊断方法。
Am J Pathol. 1997 May;150(5):1511-21.
3
Molecular biology of prostate cancer.前列腺癌的分子生物学
World J Urol. 1996;14(5):318-28. doi: 10.1007/BF00184605.
4
P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer.P53肿瘤抑制基因突变主要定位于人类原发性和转移性前列腺癌的第7外显子。
Br J Cancer. 1996 Jul;74(2):264-8. doi: 10.1038/bjc.1996.349.
5
p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries.日本人类前列腺癌中的p53基因突变:日本与西方国家之间不同的突变谱
Jpn J Cancer Res. 1994 Sep;85(9):904-10. doi: 10.1111/j.1349-7006.1994.tb02967.x.
6
Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.人类前列腺癌中的肿瘤内细胞异质性以及ras癌基因和p53肿瘤抑制基因的改变。
Am J Pathol. 1995 Oct;147(4):1112-22.
7
A microdissection approach to detect molecular markers during progression of prostate cancer.一种在前列腺癌进展过程中检测分子标志物的显微切割方法。
Br J Cancer. 1995 Oct;72(4):946-51. doi: 10.1038/bjc.1995.439.